TY - JOUR
T1 - Beetroot juice does not enhance altitude running performance in well-trained athletes
AU - Arnold, J
AU - Oliver, S
AU - Lewis-Jones, T
AU - Wylie, L
AU - Macdonald, J
PY - 2015/2/4
Y1 - 2015/2/4
N2 - We hypothesized that acute dietary nitrate (NO3–) provided as concentrated beetroot juice supplement would improve endurance running performance of well-trained runners in normobaric hypoxia. Ten male runners (mean (SD): sea level maximal oxygen uptake, 66 (7) mL·kg–1·min−1; 10 km personal best, 36 (2) min) completed incremental exercise to exhaustion at 4000 m and a 10-km treadmill time-trial at 2500 m simulated altitude on separate days after supplementation with ∼7 mmol NO3– and a placebo at 2.5 h before exercise. Oxygen cost, arterial oxygen saturation, heart rate, and ratings of perceived exertion (RPE) were determined during the incremental exercise test. Differences between treatments were determined using means [95% confidence intervals], paired sample t tests, and a probability of individual response analysis. NO3– supplementation increased plasma nitrite concentration (NO3–, 473 (226) nmol·L–1 vs. placebo, 61 (37) nmol·L–1, P < 0.001) but did not alter time to exhaustion during the incremental test (NO3–, 402 (80) s vs. placebo 393 (62) s, P = 0.5) or time to complete the 10-km time-trial (NO3–, 2862 (233) s vs. placebo, 2874 (265) s, P = 0.6). Further, no practically meaningful beneficial effect on time-trial performance was observed as the 11 [–60 to 38] s improvement was less than the a priori determined minimum important difference (51 s), and only 3 runners experienced a “likely, probable” performance improvement. NO3– also did not alter oxygen cost, arterial oxygen saturation, heart rate, or RPE. Acute dietary NO3– supplementation did not consistently enhance running performance of well-trained athletes in normobaric hypoxia.
AB - We hypothesized that acute dietary nitrate (NO3–) provided as concentrated beetroot juice supplement would improve endurance running performance of well-trained runners in normobaric hypoxia. Ten male runners (mean (SD): sea level maximal oxygen uptake, 66 (7) mL·kg–1·min−1; 10 km personal best, 36 (2) min) completed incremental exercise to exhaustion at 4000 m and a 10-km treadmill time-trial at 2500 m simulated altitude on separate days after supplementation with ∼7 mmol NO3– and a placebo at 2.5 h before exercise. Oxygen cost, arterial oxygen saturation, heart rate, and ratings of perceived exertion (RPE) were determined during the incremental exercise test. Differences between treatments were determined using means [95% confidence intervals], paired sample t tests, and a probability of individual response analysis. NO3– supplementation increased plasma nitrite concentration (NO3–, 473 (226) nmol·L–1 vs. placebo, 61 (37) nmol·L–1, P < 0.001) but did not alter time to exhaustion during the incremental test (NO3–, 402 (80) s vs. placebo 393 (62) s, P = 0.5) or time to complete the 10-km time-trial (NO3–, 2862 (233) s vs. placebo, 2874 (265) s, P = 0.6). Further, no practically meaningful beneficial effect on time-trial performance was observed as the 11 [–60 to 38] s improvement was less than the a priori determined minimum important difference (51 s), and only 3 runners experienced a “likely, probable” performance improvement. NO3– also did not alter oxygen cost, arterial oxygen saturation, heart rate, or RPE. Acute dietary NO3– supplementation did not consistently enhance running performance of well-trained athletes in normobaric hypoxia.
U2 - 10.1139/apnm-2014-0470
DO - 10.1139/apnm-2014-0470
M3 - Article
VL - 40
JO - Applied Physiology Nutrition and Metabolism
JF - Applied Physiology Nutrition and Metabolism
SN - 1715-5312
IS - 6
ER -